Your top news on healthcare and wellness
Provided by AGPStay up to date with press releases covering announcements, company news, product launches, and business updates.
Publish your press release
GlobeNewswire, Inc.
SAN MATEO, Calif., May 21, 2026 (GLOBE NEWSWIRE) -- Asher Biotherapeutics (Asher Bio), a clinical-stage biotechnology company developing precisely-targeted immunotherapies for cancer, today announced two upcoming presentations at the 2026 American...
GlobeNewswire, Inc.
One new responder observed in the [212Pb]VMT01 3.0 mCi monotherapy cohort for a total of two confirmed responses out of seven (29%) treated in this cohort of the Phase 1/2a study in heavily pre-treated melanoma; further data expected in late 2026...
GlobeNewswire, Inc.
CTX-8371, a novel dual checkpoint blocker that simultaneously targets the programmed death receptor PD-1 and its ligand PD-L1, demonstrated promising monotherapy clinical activity in patients with advanced malignancies resistant to prior immune...
Illinois House Democratic Caucus
SPRINGFIELD, Ill. – State Rep. Yolonda Morris, D-Chicago, advanced legislation to the governor’s desk that would protect Illinois patients from losing their homes because of unpaid medical debt. “No one should fear losing their home because they...
Royal College of Physicians
The RCP has published a new edition of Commentary, bringing together fresh perspectives, expert insight and stories from across the physician community.
GlobeNewswire, Inc.
Presentations to cover progress across Eikon’s most advanced clinical-stage programs Updated data will include those derived from trials of EIK1001, for the treatment of patients with non-small cell lung cancer (“NSCLC”), EIK1003, as a monotherapy...
GlobeNewswire, Inc.
Phase 1 Data Shows a 43% Overall Response Rate at the Recommended Phase 2 Dose and Durable Responses Exceeding One Year and Ongoing, with a Favorable Safety Profile Anti-Tumor Activity Seen Across ACC Subtypes and Regardless of Prior Lines of...
GlobeNewswire, Inc.
OP-3136 monotherapy was well-tolerated with no dose-limiting toxicities observed and no discontinuations due to treatment-related adverse events OP-3136 shows evidence of anti-tumor activity across multiple solid tumor types Data support the...
GlobeNewswire, Inc.
LONDON and GAITHERSBURG, Md., May 21, 2026 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), a commercial-stage biopharmaceutical company developing, manufacturing and delivering next-generation programmed T cell therapies and...
GlobeNewswire, Inc.
REDWOOD CITY, Calif., May 21, 2026 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced that members of...
GlobeNewswire, Inc.
SAN JOSE, Calif., May 21, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM), a medical technology company pioneering a first of-its-kind technology to improve clinical outcomes in dialysis with less cost and complexity (the “Company”),...
GlobeNewswire, Inc.
In an all-comer PROC population, across multiple dose cohorts, manageable safety profile of the combination was observed with low frequency of high-grade adverse events Activity of the combined regimen across all dose cohorts achieved 39% ORR and...
GlobeNewswire, Inc.
Highlights FORTIFY, the Phase 1b indication expansion trial of PLN-101095 enrolling patients with ICI-refractory solid tumors SOUTH SAN FRANCISCO, Calif., May 21, 2026 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX) today announced a...
GlobeNewswire, Inc.
New York City, NY, May 21, 2026 (GLOBE NEWSWIRE) -- Understanding Medical Malpractice in Queens New York Hospitals throughout New York face liability for infections and injuries occurring during patient stays.
EIN Presswire
BURLINGAME, CA, UNITED STATES, May 20, 2026 /EINPresswire.com/ -- The latest research study published by Coherent Market Insights on the "Medical Aesthetics Market Forecast 2026–2033" delivers precise economic insights along with global and...
EIN Presswire
LezDo TechMed expands nationwide, delivering fast, accurate, and reliable medical record review support for legal and insurance teams.
GlobeNewswire, Inc.
SANDY, UTAH, May 21, 2026 (GLOBE NEWSWIRE) -- Mental health care in the Salt Lake Valley is getting a major boost thanks to an investment by Intermountain Health in a new state-of-the-art Behavior Health Center in Sandy, Utah that will...
EIN Presswire
FMCA is proud to announce the recipients of the FMCA Community Impact Scholarships for the September 2026 Health Coach Certification Program CHICAGO, IL, UNITED STATES, May 21, 2026 /EINPresswire.com/ -- This spring, over 600 applicants shared...
GlobeNewswire, Inc.
New York, USA, May 21, 2026 (GLOBE NEWSWIRE) -- Cutaneous T-Cell Lymphoma Clinical Trial Pipeline Accelerates as 30+ Pharma Companies Rigorously Developing Drugs for Market Entry | DelveInsight The cutaneous T-cell lymphoma clinical trial analysis...
EIN Presswire
Integration of GMR’s expertise and scale promises to accelerate standardized quality measures and elevate emergency medical services industry-wide LEWISVILLE, TX, UNITED STATES, May 21, 2026 /EINPresswire.com/ -- The National EMS Quality...
Sign up for:
The daily local news briefing you can trust. Every day. Subscribe now.
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
is already signed up. Check your inbox for updates.